Kyverna Therapeutics reported net income of -$38.37M for the quarter ended Jun 2026. This income statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.02M | 0.63M | 0.66M | 0.67M | 23.75M | 43.15M | 43.17M | 43.21M | 43.22M | 43.24M | 43.79M | 44.26M | 60.53M | 61.57M |
| Operating items | ||||||||||||||
| Research & DevelopmentR&D | 8.71M | 10.40M | 13.64M | 17.16M | 22.48M | 27.32M | 29.19M | 33.48M | 37.43M | 35.82M | 30.46M | 30.01M | 30.07M | 24.79M |
| Selling, General & AdministrativeSG&A | 2.73M | 2.90M | 2.64M | 4.21M | 6.88M | 6.11M | 9.58M | 7.56M | 9.97M | 8.59M | 8.27M | 9.27M | 11.29M | 14.77M |
| Operating ExpensesOpex | 11.45M | 13.30M | 16.28M | 21.38M | 29.36M | 33.44M | 38.77M | 41.04M | 47.41M | 44.41M | 38.73M | 39.28M | 41.37M | 39.56M |
| Operating IncomeOp. Inc | -11.45M | -13.30M | -16.28M | -21.38M | -29.36M | -33.44M | -38.77M | -41.04M | -47.41M | -44.41M | -38.73M | -39.28M | -41.37M | -39.56M |
| EBIT | -11.45M | -13.30M | -16.28M | -21.38M | -29.36M | -33.44M | -38.77M | -41.04M | -47.41M | -44.41M | -38.73M | -39.28M | -41.37M | -39.56M |
| Non-operating items | ||||||||||||||
| Non Operating Interest Expenses | 0.04M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.03M | 0.01M | 0.01M | 0.44M | 0.67M | 0.67M |
| Interest & Investment IncomeInt & Inv Inc | 0.35M | 0.26M | 0.88M | 0.79M | 2.73M | 4.69M | 4.36M | 3.58M | 2.83M | 2.36M | 2.00M | 1.91M | 2.33M | 1.93M |
| Other Non Operating IncomeOther Non Op Inc. | -0.00M | -0.01M | -0.01M | -0.03M | -0.03M | -0.02M | -0.04M | 0.00M | -0.03M | -0.02M | -0.05M | 0.02M | -0.02M | -0.02M |
| Non Operating IncomeNon Op. Inc. | 0.30M | 0.21M | 0.82M | 0.71M | 2.67M | 4.63M | 4.28M | 3.55M | 2.77M | 2.33M | 1.94M | 1.48M | 1.64M | 1.24M |
| Net income details | ||||||||||||||
| EBT | -11.14M | -13.08M | -15.45M | -20.64M | -26.67M | -28.78M | -34.45M | -37.49M | -44.61M | -42.06M | -36.73M | -37.82M | -39.71M | -38.30M |
| Profit After TaxPAT | -11.14M | -13.09M | -15.46M | -20.70M | -26.69M | -28.80M | -34.49M | -37.50M | -44.63M | -42.10M | -36.79M | -37.74M | -39.73M | -38.37M |
| Income from Continuing OperationsIncome (Continuing) | -11.14M | -13.08M | -15.45M | -20.64M | -26.67M | -28.78M | -34.45M | -37.49M | -44.61M | -42.06M | -36.73M | -37.82M | -39.71M | -38.30M |
| Consolidated Net IncomeConsol Net Inc. | -11.14M | -13.08M | -15.45M | -20.64M | -26.67M | -28.78M | -34.45M | -37.49M | -44.61M | -42.06M | -36.73M | -37.82M | -39.71M | -38.30M |
| Income towards Parent CompanyParent Net Inc | -11.14M | -13.08M | -15.45M | -20.64M | -26.67M | -28.78M | -34.45M | -37.49M | -44.61M | -42.06M | -36.73M | -37.82M | -39.71M | -38.30M |
| Net Income towards Common StockholdersNet Income | -11.14M | -13.08M | -15.45M | -20.64M | -26.67M | -28.78M | -34.45M | -37.49M | -44.61M | -42.06M | -36.73M | -37.82M | -39.71M | -38.30M |
| Additional items | ||||||||||||||
| EPS (Basic) | -12.09 | -20.85 | -23.25 | -30.63 | -1.12 | -0.67 | -0.80 | -0.98 | -1.03 | -0.97 | -0.85 | -0.85 | -0.66 | -0.63 |
| EPS (Diluted) | -12.09 | -20.85 | -23.25 | -30.63 | -1.12 | -0.67 | -0.80 | -0.98 | -1.03 | -0.97 | -0.85 | -0.85 | -0.66 | -0.63 |
| Shares Outstanding | 0.92M | 0.63M | 0.66M | 0.67M | 23.75M | 43.13M | 43.16M | 38.33M | 43.22M | 43.23M | 43.42M | 44.26M | 60.43M | 60.90M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 0.92M | 0.63M | 0.66M | 0.67M | 23.75M | 43.13M | 43.16M | 38.33M | 43.22M | 43.23M | 43.42M | 44.26M | 60.43M | 60.90M |
| EBITDA | -11.45M | -13.30M | -16.28M | -21.38M | -29.36M | -33.44M | -38.77M | -41.04M | -47.41M | -44.41M | -38.73M | -39.28M | -41.37M | -39.56M |
| Interest ExpensesInt Expense | 0.04M | 0.05M | 0.05M | 0.05M | 0.04M | 0.04M | 0.03M | 0.03M | 0.03M | 0.01M | 0.01M | 0.44M | 0.67M | 0.67M |